190 related articles for article (PubMed ID: 11724743)
1. Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan.
Katugampola SD; Davenport AP
Br J Pharmacol; 2001 Dec; 134(7):1385-92. PubMed ID: 11724743
[TBL] [Abstract][Full Text] [Related]
2. Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the rat.
Valentin JP; Jover B; Maffre M; Bertolino F; Bessac AM; John GW
Am J Hypertens; 1997 Sep; 10(9 Pt 1):1058-63. PubMed ID: 9324114
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2 receptors in equine monocytes: identification of a new subclass of TXA2 receptors.
Simmons TR; Cook JA; Moore JN; Halushka PV
J Leukoc Biol; 1993 Feb; 53(2):173-8. PubMed ID: 8383167
[TBL] [Abstract][Full Text] [Related]
4. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
[TBL] [Abstract][Full Text] [Related]
5. Structural determinants for agonist binding affinity to thromboxane/prostaglandin endoperoxide (TP) receptors. Analysis of chimeric rat/human TP receptors.
Dorn GW; Davis MG; D'Angelo DD
J Biol Chem; 1997 May; 272(19):12399-405. PubMed ID: 9139686
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets.
Habib A; FitzGerald GA; Maclouf J
J Biol Chem; 1999 Jan; 274(5):2645-51. PubMed ID: 9915793
[TBL] [Abstract][Full Text] [Related]
7. Glomerular thromboxane A2/prostaglandin H2 receptors: characterization and effect of adriamycin-induced nephrotic syndrome.
Mayeux PR; Shah SV
Biochim Biophys Acta; 1993 Apr; 1181(2):148-54. PubMed ID: 8481403
[TBL] [Abstract][Full Text] [Related]
8. Reduction in the number of thromboxane receptors on human platelets after exposure to GR32191.
Armstrong RA; Humphrey PP; Lumley P
Br J Pharmacol; 1993 Oct; 110(2):548-52. PubMed ID: 8242229
[TBL] [Abstract][Full Text] [Related]
9. Comparative study on the effect of aspirin, TP receptor antagonist and TxA
Ozen G; Aljesri K; Abdelazeem H; Norel X; Turkyılmaz G; Turkyılmaz S; Topal G
Life Sci; 2021 Dec; 286():120073. PubMed ID: 34688694
[TBL] [Abstract][Full Text] [Related]
10. Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.
Davenport AP; Kuc RE; Ashby MJ; Patt WC; Doherty AM
Br J Pharmacol; 1998 Jan; 123(2):223-30. PubMed ID: 9489609
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic effects of losartan on thromboxane A2-receptors in human isolated gastroepiploic artery and saphenous vein.
Tripodi F; Stanke-Labesque F; Devillier P; Chavanon O; Sessa C; Bessard G
J Cardiovasc Pharmacol; 1999 Nov; 34(5):734-40. PubMed ID: 10547091
[TBL] [Abstract][Full Text] [Related]
12. [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis.
Katugampola SD; Pallikaros Z; Davenport AP
Br J Pharmacol; 2001 Sep; 134(1):143-9. PubMed ID: 11522606
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the prostanoid TP receptor population in human nonpregnant myometrium.
Senchyna M; Crankshaw DJ
J Pharmacol Exp Ther; 1996 Oct; 279(1):262-70. PubMed ID: 8859002
[TBL] [Abstract][Full Text] [Related]
14. DuP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet thromboxane A2/prostaglandin H2 (TP) receptors.
Liu EC; Hedberg A; Goldenberg HJ; Harris DN; Webb ML
Prostaglandins; 1992 Aug; 44(2):89-99. PubMed ID: 1438880
[TBL] [Abstract][Full Text] [Related]
15. Evidence for partial agonist properties of daltroban (BM 13,505) at TP receptors in the anaesthetized open-chest rat.
Bertolino F; Valentin JP; Patoiseau JF; Rieu JP; Colpaert FC; John GW
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):462-6. PubMed ID: 9349632
[TBL] [Abstract][Full Text] [Related]
16. Modification on ligand binding to TXA2/PGH2 receptors by diethylpyrocarbonate.
Schrör K; Davis-Bruno K; Halushka PV
Adv Exp Med Biol; 1997; 400A():235-40. PubMed ID: 9547563
[No Abstract] [Full Text] [Related]
17. Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries.
Siangjong L; Gauthier KM; Pfister SL; Smyth EM; Campbell WB
Am J Physiol Heart Circ Physiol; 2013 Feb; 304(3):H382-92. PubMed ID: 23203967
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a rat kidney thromboxane A2 receptor: high affinity for the agonist ligand I-BOP.
D'Angelo DD; Terasawa T; Carlisle SJ; Dorn GW; Lynch KR
Prostaglandins; 1996 Oct; 52(4):303-16. PubMed ID: 8936585
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling.
Schwemmer M; Sommer O; Bassenge E
Cardiovasc Drugs Ther; 2001 Jul; 15(4):301-7. PubMed ID: 11800413
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of phosphatidylinositol 3-kinase and of the thromboxane A2 (TXA2) receptor by the TXA2 mimetic I-BOP in A7r5 cells.
Morinelli TA; Finley EL; Jaffa AA; Kurtz DT; Ullian ME
Biochem Pharmacol; 1997 Jun; 53(12):1823-32. PubMed ID: 9256157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
